D-dimer and C-reactive Protein Blood Levels Over Time Used to Predict Pulmonary Embolism in Two COVID-19 Patients

The diagnosis of pulmonary embolism is challenging in symptomatic COVID-19 patients since shortness of breath, chest pain, tachycardia, tachypnoea, fever, oxygen desaturation and high D-dimer blood levels might be features of both diseases. We present two COVID-19 patients in whom pulmonary embolism...

Full description

Bibliographic Details
Main Authors:	Yael Becher, Leonid Goldman, Nadav Schacham, Irina Gringauz, Dan Justo
Format:	Article
Language:	English
Published:	SMC MEDIA SRL 2020-05-01
Series:	European Journal of Case Reports in Internal Medicine
Subjects:	covid-19 c-reactive protein d-dimer pulmonary embolism
Online Access:	https://www.ejcrim.com/index.php/EJCRIM/article/view/1725

id	doaj-cbf1a183213348bface7b0975296389b
record_format	Article
spelling	doaj-cbf1a183213348bface7b0975296389b2020-11-25T03:17:38ZengSMC MEDIA SRLEuropean Journal of Case Reports in Internal Medicine2284-25942020-05-0110.12890/2020_0017251359D-dimer and C-reactive Protein Blood Levels Over Time Used to Predict Pulmonary Embolism in Two COVID-19 PatientsYael Becher0Leonid Goldman1Nadav Schacham2Irina Gringauz3Dan Justo4Geriatrics and Internal Medicine B Department, Sheba Medical Center, Ramat-Gan, Israel; Aff. to Sackler School of Medicine, Tel-Aviv University, IsraelGeriatrics and Internal Medicine B Department, Sheba Medical Center, Ramat-Gan, Israel; Aff. to Sackler School of Medicine, Tel-Aviv University, IsraelGeriatrics and Internal Medicine B Department, Sheba Medical Center, Ramat-Gan, Israel; Aff. to Sackler School of Medicine, Tel-Aviv University, IsraelGeriatrics and Internal Medicine B Department, Sheba Medical Center, Ramat-Gan, Israel; Aff. to Sackler School of Medicine, Tel-Aviv University, IsraelGeriatrics and Internal Medicine B Department, Sheba Medical Center, Ramat-Gan, Israel; Aff. to Sackler School of Medicine, Tel-Aviv University, IsraelThe diagnosis of pulmonary embolism is challenging in symptomatic COVID-19 patients since shortness of breath, chest pain, tachycardia, tachypnoea, fever, oxygen desaturation and high D-dimer blood levels might be features of both diseases. We present two COVID-19 patients in whom pulmonary embolism was suspected (and diagnosed) due to a discrepancy between an increase in D-dimer blood levels and a decrease in C-reactive protein blood levels over time. We believe that an opposite change in the blood levels of both biomarkers over time may be used as a novel method to predict pulmonary embolism in COVID-19 patients.https://www.ejcrim.com/index.php/EJCRIM/article/view/1725covid-19c-reactive proteind-dimerpulmonary embolism
collection	DOAJ
language	English
format	Article
sources	DOAJ
author	Yael Becher Leonid Goldman Nadav Schacham Irina Gringauz Dan Justo
spellingShingle	Yael Becher Leonid Goldman Nadav Schacham Irina Gringauz Dan Justo D-dimer and C-reactive Protein Blood Levels Over Time Used to Predict Pulmonary Embolism in Two COVID-19 Patients European Journal of Case Reports in Internal Medicine covid-19 c-reactive protein d-dimer pulmonary embolism
author_facet	Yael Becher Leonid Goldman Nadav Schacham Irina Gringauz Dan Justo
author_sort	Yael Becher
title	D-dimer and C-reactive Protein Blood Levels Over Time Used to Predict Pulmonary Embolism in Two COVID-19 Patients
title_short	D-dimer and C-reactive Protein Blood Levels Over Time Used to Predict Pulmonary Embolism in Two COVID-19 Patients
title_full	D-dimer and C-reactive Protein Blood Levels Over Time Used to Predict Pulmonary Embolism in Two COVID-19 Patients
title_fullStr	D-dimer and C-reactive Protein Blood Levels Over Time Used to Predict Pulmonary Embolism in Two COVID-19 Patients
title_full_unstemmed	D-dimer and C-reactive Protein Blood Levels Over Time Used to Predict Pulmonary Embolism in Two COVID-19 Patients
title_sort	d-dimer and c-reactive protein blood levels over time used to predict pulmonary embolism in two covid-19 patients
publisher	SMC MEDIA SRL
series	European Journal of Case Reports in Internal Medicine
issn	2284-2594
publishDate	2020-05-01
description	The diagnosis of pulmonary embolism is challenging in symptomatic COVID-19 patients since shortness of breath, chest pain, tachycardia, tachypnoea, fever, oxygen desaturation and high D-dimer blood levels might be features of both diseases. We present two COVID-19 patients in whom pulmonary embolism was suspected (and diagnosed) due to a discrepancy between an increase in D-dimer blood levels and a decrease in C-reactive protein blood levels over time. We believe that an opposite change in the blood levels of both biomarkers over time may be used as a novel method to predict pulmonary embolism in COVID-19 patients.
topic	covid-19 c-reactive protein d-dimer pulmonary embolism
url	https://www.ejcrim.com/index.php/EJCRIM/article/view/1725
work_keys_str_mv	AT yaelbecher ddimerandcreactiveproteinbloodlevelsovertimeusedtopredictpulmonaryembolismintwocovid19patients AT leonidgoldman ddimerandcreactiveproteinbloodlevelsovertimeusedtopredictpulmonaryembolismintwocovid19patients AT nadavschacham ddimerandcreactiveproteinbloodlevelsovertimeusedtopredictpulmonaryembolismintwocovid19patients AT irinagringauz ddimerandcreactiveproteinbloodlevelsovertimeusedtopredictpulmonaryembolismintwocovid19patients AT danjusto ddimerandcreactiveproteinbloodlevelsovertimeusedtopredictpulmonaryembolismintwocovid19patients
_version_	1724630938651983872

D-dimer and C-reactive Protein Blood Levels Over Time Used to Predict Pulmonary Embolism in Two COVID-19 Patients

Similar Items